Publisher
American Association for Cancer Research (AACR)
Cited by
91 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design, synthesis, and anticancer assessment of structural analogues of (E)-1-((3,4,5-trimethoxybenzylidene)amino)-4-(3,4,5-trimethoxyphenyl)imidazo[1,2-a]quinoxaline-2-carbonitrile (6b), an imidazo[1,2-a]quinoxaline-based non-covalent EGFR inhibitor;RSC Medicinal Chemistry;2024
2. Synthesis, Antitumor Activities, and Molecular Modeling of 4-Anilinoquinazoline Derivatives as EGFR-TK Inhibitors;Pharmaceutical Chemistry Journal;2023-11
3. The development and implementation of EGFR inhibitors in advanced NSCLC;Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC;2023
4. Photoresponsive Nanocarriers Based on Lithium Niobate Nanoparticles for Harmonic Imaging and On-Demand Release of Anticancer Chemotherapeutics;ACS Nanoscience Au;2022-06-03
5. Targeting EGFR, RSK1, RAF1, PARP2 and LIN28B for several cancer type therapies with newly synthesized pyrazole derivatives via a computational study;Journal of Biomolecular Structure and Dynamics;2022-04-20